KR20190010728A - Osteoclast inhibitors for pain - Google Patents

Osteoclast inhibitors for pain Download PDF

Info

Publication number
KR20190010728A
KR20190010728A KR1020197002069A KR20197002069A KR20190010728A KR 20190010728 A KR20190010728 A KR 20190010728A KR 1020197002069 A KR1020197002069 A KR 1020197002069A KR 20197002069 A KR20197002069 A KR 20197002069A KR 20190010728 A KR20190010728 A KR 20190010728A
Authority
KR
South Korea
Prior art keywords
mg
zoledronic acid
kg
embodiments
pain
Prior art date
Application number
KR1020197002069A
Other languages
Korean (ko)
Inventor
헤리엇 타부토
에릭 케이 엠 딘클라
그레이엄 존스
Original Assignee
안테씨프 바이오벤쳐스 투 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US14/288,241 priority Critical patent/US8901161B1/en
Priority to US14/288,241 priority
Priority to US14/288,713 priority patent/US8901162B1/en
Priority to US14/288,720 priority patent/US8865757B1/en
Priority to US14/288,720 priority
Priority to US14/288,716 priority
Priority to US14/288,716 priority patent/US8835650B1/en
Priority to US14/288,713 priority
Priority to US201462012112P priority
Priority to US62/012,112 priority
Priority to US14/310,811 priority
Priority to US14/310,811 priority patent/US8822436B1/en
Priority to US14/336,642 priority
Priority to US14/336,642 priority patent/US20140329773A1/en
Priority to US14/446,184 priority patent/US9006279B1/en
Priority to US14/446,184 priority
Priority to PCT/US2014/050427 priority patent/WO2015060924A1/en
Priority to USPCT/US2014/050427 priority
Priority to US14/457,659 priority patent/US20140349974A1/en
Priority to US14/457,659 priority
Priority to US14/481,097 priority patent/US8962599B1/en
Priority to US14/481,097 priority
Priority to US62/053,619 priority
Priority to US201462053619P priority
Priority to US14/495,732 priority
Priority to US14/495,732 priority patent/US9127069B1/en
Priority to US14/530,556 priority
Priority to US14/530,556 priority patent/US20150051175A1/en
Priority to US14/536,526 priority patent/US20150057250A1/en
Priority to US14/536,526 priority
Priority to US14/538,709 priority
Priority to US14/538,709 priority patent/US9290575B2/en
Priority to US14/540,333 priority patent/US9216168B1/en
Priority to US14/540,333 priority
Priority to US14/604,524 priority patent/US9211257B2/en
Priority to US14/604,524 priority
Priority to US14/605,822 priority
Priority to US14/605,822 priority patent/US9216153B2/en
Priority to US14/607,947 priority patent/US9289384B2/en
Priority to US14/607,985 priority
Priority to US14/607,985 priority patent/US9289385B2/en
Priority to US14/607,947 priority
Priority to US14/608,855 priority
Priority to US14/608,855 priority patent/US9079927B1/en
Priority to US14/625,457 priority patent/US9427403B2/en
Priority to US14/625,457 priority
Priority to US62/127,214 priority
Priority to US201562127214P priority
Priority to US14/635,857 priority
Priority to US14/635,857 priority patent/US9283239B2/en
Priority to US14/639,013 priority patent/US9289441B2/en
Priority to US14/639,013 priority
Priority to US14/686,551 priority patent/US9408860B2/en
Priority to US14/686,551 priority
Application filed by 안테씨프 바이오벤쳐스 투 엘엘씨 filed Critical 안테씨프 바이오벤쳐스 투 엘엘씨
Priority to PCT/US2015/032739 priority patent/WO2015184003A1/en
Publication of KR20190010728A publication Critical patent/KR20190010728A/en

Links